000 | 01113 a2200289 4500 | ||
---|---|---|---|
005 | 20250514015813.0 | ||
264 | 0 | _c20011213 | |
008 | 200112s 0 0 eng d | ||
022 | _a0003-9926 | ||
024 | 7 |
_a10.1001/archinte.161.21.2622 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aMehta, M | |
245 | 0 | 0 |
_aPDR provides latest Food and Drug Administration-approved dosage guidelines. _h[electronic resource] |
260 |
_bArchives of internal medicine _cNov 2001 |
||
300 |
_a2622; author reply 2623 p. _bdigital |
||
500 | _aPublication Type: Comment; Letter | ||
650 | 0 | 4 |
_aAntihypertensive Agents _xadministration & dosage |
650 | 0 | 4 | _aDrug Administration Schedule |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 |
_aHypertension _xdrug therapy |
650 | 0 | 4 | _aPractice Guidelines as Topic |
650 | 0 | 4 | _aReference Books, Medical |
650 | 0 | 4 | _aUnited States |
650 | 0 | 4 | _aUnited States Food and Drug Administration |
773 | 0 |
_tArchives of internal medicine _gvol. 161 _gno. 21 _gp. 2622; author reply 2623 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.1001/archinte.161.21.2622 _zAvailable from publisher's website |
999 |
_c11633083 _d11633083 |